AlphaFold predicted structure
UMPS · P11172

Mean pLDDT
92.1/ 100
Very high
480 residues
Confidence breakdown
- Very high(≥ 90)83%
- Confident(70–90)10%
- Low(50–70)3%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
uridine monophosphate synthetase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
orotic aciduria
Hereditary orotic aciduria
coronary artery disorder
Intellectual disability
psoriasis vulgaris
Abnormality of the skeletal system
coronary atherosclerosis
hereditary disease
cardiomyopathy
heart disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Uridine 5'-monophosphate synthase
Bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT), which converts orotate to orotidine-5'-monophosphate (OMP), and orotidine-5'-monophosphate decarboxylase (ODC), the terminal enzymatic reaction that decarboxylates OMP to uridine monophosphate (UMP)
UMPS · P11172

Mean pLDDT
92.1/ 100
Very high
480 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0